Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma.
Houda BahigFrancine AubinJohn StaggOlguta GologanOlivier BallivyEric BissadaFelix-Phuc Nguyen-TanDenis SoulièresLouis GuertinEdith FilionApostolos ChristopoulosLouise LambertMustapha TehfeTareck AyadDanielle CharpentierRahima JamalPhilip WongPublished in: BMC cancer (2019)
NCT03283605 . Registration date: September 14, 2017; version 1.